A new class of cancer drugs just now entering the marketplace seems promising so far, but researchers at the University of Illinois at Chicago urge doctors to take into account a patient's weight and liver status before prescribing them once they come on the market
Not about prostate cancer specifically, but we were talking about adjusting dose to body weight, and paying attention to liver condition.
Written by
cesanon
To view profiles and participate in discussions please or .
I do a wt-adj dose with all prescribed drugs being a small person at 145 lbs. Zytiga: 1/2 dose per day with tsbp yogurt, Lupron: monthly shot every six weeks. Seems to be working so far, PSA < 0.1 one month after HDR-BT.
Purely on weight, based on average US male ave weight of 197lbs. First month on full dose of Zytiga liver enzymes bumped up to about 1.5 ULN, not extraordinary. Following month on 3/4 dose they got better, and now on 1/2 dose all are in range. Still taking 2x2.5mg Prednisone. Taking Zytiga with a bit of yogurt to boost the dose. Read that lower doses within range of full efficacy actually increase time to CR. Further read that European standard for Lupron is 11.5mg per three months, 1/2 the US dose.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.